Biophytis' IPO

Biophytis raised a round of funding on July 13, 2015. Investors include Public.

Biophytis is developing a portfolio of nutraceuticals and drug candidates derived from active natural substances targeted at metabolic disorders and age-related diseases.…

Articles about Biophytis' IPO: